Ishare Nq Biotch ETF (IBB) 294.15 $IBB Watch for iShares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ishare Nq Biotch ETF (IBB) 294.15 $IBB

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 1.41% Yesterday
Comtex SmarTrend(R) - 1 hr 18 mins ago
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $289.87 to a high of $296.84. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $289.77 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 294.15 (+4.71)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.41% Rise
Comtex SmarTrend(R) - 1 hr 19 mins ago
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $289.87 to a high of $296.84. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $289.77 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 294.15 (+4.71)

Analyzing a Politically Sensitive Group of ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Jul 29, 9:48AM CDT
Few corners of the market have been endured presidential election year volatility on par with biotechnology stocks and exchange traded funds such as the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB). Actually, political headwinds faced by IBB and...
IBB: 294.15 (+4.71)

Analysts Forecast 28% Upside For The Holdings of IBB
ETFChannel.com - Thu Jul 28, 6:31AM CDT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst...
IBB: 294.15 (+4.71)

iShares Nasdaq Biotechnology Index Rises 1.45% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jul 27, 1:06PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $280.25 to a high of $284.98. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $282.74 on volume of 613,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 294.15 (+4.71)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 1.45% Gain
Comtex SmarTrend(R) - Wed Jul 27, 1:05PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $280.25 to a high of $284.98. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $282.74 on volume of 613,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 294.15 (+4.71)

Biotech ETFs: Will the Once Hot Group Rebound?
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jul 13, 8:00AM CDT
The struggling biotechnology group and exchange traded funds such as the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, are leaving investors wondering when this once hot corner of the market will...
FBT: 102.70 (+2.44), XBI: 63.64 (+1.57), IBB: 294.15 (+4.71)

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.80%
Comtex SmarTrend(R) - Tue Jun 21, 12:19PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $252.86 to a high of $259.50. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $256.34 on volume of 785,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 294.15 (+4.71)

Vista Partners Publishes June 2016 Macroeconomic & Investment Newsletter
Marketwire Canada - Tue Jun 21, 8:01AM CDT
Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Big Data, Biotechnology, Fintech, Healthcare, IoT, SaaS, Sports, WearableTech & More
IBB: 294.15 (+4.71), IMNP: 0.38 (-0.02)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 1.20% Sell Off
Comtex SmarTrend(R) - Fri Jun 17, 12:13PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $257.55 to a high of $262.99. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $258.19 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 294.15 (+4.71)

After Yesterday's Decline of 1.11%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jun 13, 12:09PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $264.04 to a high of $269.98. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $266.20 on volume of 893,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 294.15 (+4.71)

The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology, Biogen, Alexion Pharma, BioMarin Pharma and Regeneron
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:30AM CDT
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology, Biogen, Alexion Pharma, BioMarin Pharma and Regeneron
BIIB: 302.77 (+12.84), BMRN: 100.10 (+0.68), ALXN: 133.02 (+4.42), IBB: 294.15 (+4.71), REGN: 433.54 (+8.42)

4 Stocks That Crushed the Biotechnology ETF (IBB) This Week
Eric Dutram - Zacks Investment Research - Fri Jun 10, 12:15PM CDT
It was a rough week for the biotechnology ETF (IBB). Which stocks pushed this key sector fund lower for the week?
BIIB: 302.77 (+12.84), BMRN: 100.10 (+0.68), SRPT: 25.81 (+0.53), ALXN: 133.02 (+4.42), IBB: 294.15 (+4.71), REGN: 433.54 (+8.42)

Watch for iShares Nasdaq Biotechnology Index to Potentially Rebound After Falling 2.31% Yesterday
Comtex SmarTrend(R) - Tue Jun 07, 11:58AM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.30 to a high of $282.65. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $277.93 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 294.15 (+4.71)

A Catalyst for Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Mon Jun 06, 7:00AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, is up 9.2% over the past month. Performances for some rival biotech ETFs have been even better and that may be setting the stage for once beloved...
FBT: 102.70 (+2.44), XBI: 63.64 (+1.57), IBB: 294.15 (+4.71)

Trying to Believe in Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Jun 03, 7:00AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs are vexing investors this year. Just when turnarounds for these funds look legitimate, they tumble again, prompting investors...
FBT: 102.70 (+2.44), XBI: 63.64 (+1.57), IBB: 294.15 (+4.71)

A Fed Focused on Legacy?
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Jun 03, 7:00AM CDT
Note: This article appears on the ETFtrends.com Strategist Channel By Dr. Vito Sciaraffia Federal Reserve Chairperson Paul Volker is remembered for taming the rampant inflation of the late 1970s-early 1980s. Present Chairperson Janet Yellen and her...
FBT: 102.70 (+2.44), XBI: 63.64 (+1.57), IBB: 294.15 (+4.71)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ultrabench Revolutionizes AI Model Comparison Game

Updated Category News Views 3

Breaking Down the Messy AI Model Landscape Ultrabench.ai is here to drag AI model comparison out of the dark ages. Picture this: 309 AI models, ranked against a whopping 530 benchmarks, all served up on one plate. If you’re navigating the AI jungle, you’ll realize how Ultrabench is no small fish in this vast ocean. Consolidating Where Others Have Scattered There's a...

Continue Reading
Varda Space's Dual Launch Signals Orbital Ambitions

Updated Category News Views 6

It's not every day you see two commercial rockets heading to orbit on the same ride, but that's precisely what Varda Space Industries just pulled off. With the W-8 and W-9 vehicles blasting off together, Varda is positioning itself for a leap in orbital operations. They've hitched a ride aboard SpaceX's Transporter-18 mission, and this is more than just a double...

Continue Reading
Managed Connectivity: Key to Modern Multifamily Living

Updated Category News Views 5

Connectivity Runs the Modern Show Imagine moving into a shiny new apartment, where the biggest hassle isn't unpacking boxes but ensuring your gadgets get online smoothly. That's the reality of today's multifamily living, where the internet is more than a utility—it's the backbone of modern life. And if you think it's just about offering internet access, you're missing...

Continue Reading
SaponiQ Reinvents Body Care with Botanical Soap Bars

Updated Category News Views 4

Breaking Through with Simple Innovation I'll be the first to say it's not every day you hear about a soap company trying to shake things up in body care like it’s a tech startup, but here’s SaponiQ taking a wild swing at it with their lineup of botanical cleansing bars. These things are whipped up in their own U.S.-based facility using some fancy cold-process...

Continue Reading
Nelson-Jameson Boosts Cold Storage in California Move

Updated Category News Views 4

An Icy Boost for the West Coast Dairy Player Every now and then, a company gets its cold storage game just right. Nelson-Jameson has added fresh muscle to its Turlock facility in California, making waves with serious logistical upgrades. The company's dogged pursuit of better operational efficiency in dairy processing isn't just about bragging rights. It's plain old good...

Continue Reading
Athlete Threats: Public Info Fuels Security Risks

Updated Category News Views 3

Public Exposure: The New Athlete Achilles' Heel Imagine sitting on millions while living in a glass house. That's the kind of predicament today's athletes find themselves in, thanks to the treasure trove of public information spilling their personal lives all over the internet. According to the latest Hush Intelligence Athlete Threat Report 2026, this very exposure has...

Continue Reading
Haystack MRD Shines in Colorectal Cancer Trials

Updated Category News Views 8

A New Dawn in Cancer Detection Just when you think you've seen it all in cancer diagnostics, Haystack MRD® pops up like a fresh tulip in spring. And listen, this ain't just fluff—the results from the DYNAMIC trials are a pretty compelling love letter to the power of liquid biopsy. With 100% specificity and sensitivity hitting a whopping 83.3% over five years, it’s...

Continue Reading
Karen Love's Retirement Marks End of an Era for TACHP

Updated Category News Views 4

A Legacy Not Just Built, But Carved in Stone In the world of healthcare, folks like Karen Love don’t come around too often. She's stepping down from her post as President and CEO of Cook Children's Health Plan this month, and it feels like the end of a chapter for the Texas Association of Community Health Plans (TACHP). Love wasn't just an executive; she was a mover and...

Continue Reading
Comparent Unveils Key Insights with Top 100 List

Updated Category News Views 8

The Ebb and Flow of Vacation Rental Giants Ever noticed how some industries just sneak up and suddenly transform landscapes? Vacation rental management is one of those sneaky offenders. At the forefront of keeping tabs on this bustling sector, Comparent just dropped a meaty second annual roster—the Comparent 100—showcasing the biggest players flexing their muscles in...

Continue Reading
Texas A&M-San Antonio's Research Expansion Momentum

Updated Category News Views 4

Texas A&M-San Antonio's Rising Research Ambitions A rainy day in San Antonio and Texas A&M University-San Antonio seems to have set the stage for more than just another semester of record enrollment. They’ve just rolled in with an exhilarating $8 million in external grants this fiscal year, more than doubling last year’s haul of $3.6 million, in a bid to push their...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Thriving Stock Opportunities Amid Political Changes

Updated Category News Views 62

The political environment in the U.S. was a wild card back in 2024, leaving traders squirming as they watched Vice President Kamala Harris hold a lead against former President Donald Trump. With a divided government lurking on the horizon, it was clear investors had to rethink their stock choices to navigate this minefield. Broadcom: Riding the AI Wave In that landscape,...

Continue Reading
Exploring the Impact of Trump Policies on Gold Prices

Updated Category News Views 565

Understanding the Potential Effects of Trump’s Policies on Gold As the political landscape evolves, many investors are closely examining how a Trump administration might influence precious metals, especially gold. Typically, it is believed that fiscal expansion and increased government spending under Trump could lead to inflation, which historically boosts gold prices....

Continue Reading
BP Explores Sale of Minority Stake in Wind Energy Initiative

Updated Category News Views 62

BP's Strategic Shift in Offshore Wind Investments BP is examining the potential sale of a minority stake in its offshore wind business, marking a significant shift in strategy under CEO Murray Auchincloss. This move comes as the energy company navigates growing pressure from shareholders regarding its energy transition plans, which were first set into motion in 2020. With...

Continue Reading
Heineken N.V. Achieves Strong Growth in Half-Year Results

Updated Category News Views 163

Heineken N.V. Reports Half-Year Results with Strong Growth Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) has officially reported its half-year results, showcasing notable profit growth and resilient performance across various regions. The report indicates a revenue of €16,924 million, highlighting the company's agility and strategic positioning in a competitive global...

Continue Reading
AAS Miner Unveils Groundbreaking Mobile Cloud Mining App

Updated Category News Views 266

Introduction to AAS Miner’s Revolutionary App In today's fast-evolving digital landscape, cryptocurrency mining has transformed dramatically. AAS Miner stands at the forefront of this revolution with its newly launched free mobile cloud mining app. This innovative tool enables users from all walks of life to easily engage in cloud mining without the need for complex...

Continue Reading